M&T Bank Corp Has $446,000 Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

M&T Bank Corp decreased its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 42.5% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 5,505 shares of the exchange traded fund’s stock after selling 4,062 shares during the quarter. M&T Bank Corp’s holdings in SPDR S&P Biotech ETF were worth $446,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently added to or reduced their stakes in the stock. Provident Wealth Management LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 3,000.0% during the 1st quarter. Provident Wealth Management LLC now owns 310 shares of the exchange traded fund’s stock valued at $25,000 after purchasing an additional 300 shares in the last quarter. Lee Danner & Bass Inc. acquired a new position in SPDR S&P Biotech ETF during the fourth quarter valued at approximately $38,000. Compass Wealth Management LLC increased its position in shares of SPDR S&P Biotech ETF by 46.0% during the 1st quarter. Compass Wealth Management LLC now owns 635 shares of the exchange traded fund’s stock worth $51,000 after purchasing an additional 200 shares during the last quarter. Golden State Wealth Management LLC raised its stake in shares of SPDR S&P Biotech ETF by 100.0% during the 1st quarter. Golden State Wealth Management LLC now owns 638 shares of the exchange traded fund’s stock worth $52,000 after purchasing an additional 319 shares in the last quarter. Finally, O Shaughnessy Asset Management LLC grew its stake in shares of SPDR S&P Biotech ETF by 38.6% in the fourth quarter. O Shaughnessy Asset Management LLC now owns 718 shares of the exchange traded fund’s stock valued at $65,000 after buying an additional 200 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of XBI opened at $87.82 on Thursday. The company has a market cap of $5.16 billion, a PE ratio of 11.47 and a beta of 0.97. The firm has a 50-day moving average of $82.38 and a 200-day moving average of $84.59. SPDR S&P Biotech ETF has a one year low of $66.66 and a one year high of $105.47.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.